198 related articles for article (PubMed ID: 34741262)
1. Enhanced Antiproliferation Potency of Electrical Pulse-Mediated Metformin and Cisplatin Combination Therapy on MDA-MB-231 Cells.
Sahu P; Camarillo IG; Sundararajan R
Appl Biochem Biotechnol; 2022 Jan; 194(1):18-36. PubMed ID: 34741262
[TBL] [Abstract][Full Text] [Related]
2. Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51.
Lee JO; Kang MJ; Byun WS; Kim SA; Seo IH; Han JA; Moon JW; Kim JH; Kim SJ; Lee EJ; In Park S; Park SH; Kim HS
Breast Cancer Res; 2019 Oct; 21(1):115. PubMed ID: 31640742
[TBL] [Abstract][Full Text] [Related]
3. Electroporation enhances cell death in 3D scaffold-based MDA-MB-231 cells treated with metformin.
Sahu P; Camarillo IG; Dettin M; Zamuner A; Teresa Conconi M; Barozzi M; Giri P; Sundararajan R; Sieni E
Bioelectrochemistry; 2024 Oct; 159():108734. PubMed ID: 38762949
[TBL] [Abstract][Full Text] [Related]
4. High-throughput, Label-Free Quantitative Proteomic Studies of the Anticancer Effects of Electrical Pulses with Turmeric Silver Nanoparticles: an in vitro Model Study.
Mittal L; Camarillo IG; Varadarajan GS; Srinivasan H; Aryal UK; Sundararajan R
Sci Rep; 2020 Apr; 10(1):7258. PubMed ID: 32350346
[TBL] [Abstract][Full Text] [Related]
5. Quantitative proteomic analysis of enhanced cellular effects of electrochemotherapy with Cisplatin in triple-negative breast cancer cells.
Mittal L; Aryal UK; Camarillo IG; Ferreira RM; Sundararajan R
Sci Rep; 2019 Sep; 9(1):13916. PubMed ID: 31558821
[TBL] [Abstract][Full Text] [Related]
6. Combining naringenin and metformin with doxorubicin enhances anticancer activity against triple-negative breast cancer in vitro and in vivo.
Pateliya B; Burade V; Goswami S
Eur J Pharmacol; 2021 Jan; 891():173725. PubMed ID: 33157041
[TBL] [Abstract][Full Text] [Related]
7. High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells.
Varghese S; Samuel SM; Varghese E; Kubatka P; Büsselberg D
Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30626087
[TBL] [Abstract][Full Text] [Related]
8. Formulation of a triple combination gemcitabine plus romidepsin + cisplatin regimen to efficaciously and safely control triple-negative breast cancer tumor development.
Pattarawat P; Wallace S; Pfisterer B; Odoi A; Wang HR
Cancer Chemother Pharmacol; 2020 Jan; 85(1):141-152. PubMed ID: 31865420
[TBL] [Abstract][Full Text] [Related]
9. Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity-An Isobolographic Analysis.
Wawruszak A; Luszczki JJ; Kalafut J; Okla K; Halasa M; Rivero-Muller A; Stepulak A
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357442
[TBL] [Abstract][Full Text] [Related]
10. Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors.
Wokoun U; Hellriegel M; Emons G; Gründker C
Oncol Rep; 2017 Apr; 37(4):2418-2424. PubMed ID: 28350075
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38.
Gohr K; Hamacher A; Engelke LH; Kassack MU
BMC Cancer; 2017 Nov; 17(1):711. PubMed ID: 29100507
[TBL] [Abstract][Full Text] [Related]
12. Apatinib enhanced anti-tumor activity of cisplatin on triple-negative breast cancer through inhibition of VEGFR-2.
Gao Z; Shi M; Wang Y; Chen J; Ou Y
Pathol Res Pract; 2019 Jul; 215(7):152422. PubMed ID: 31079851
[TBL] [Abstract][Full Text] [Related]
13. Sulforaphane-cisplatin combination inhibits the stemness and metastatic potential of TNBCs via down regulation of sirtuins-mediated EMT signaling axis.
Sinha S; Sharma S; Sharma A; Vora J; Shrivastava N
Phytomedicine; 2021 Apr; 84():153492. PubMed ID: 33640782
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin-based Electrochemotherapy Significantly Downregulates Key Heat Shock Proteins in MDA-MB-231-Human Triple-Negative Breast Cancer Cells.
Sundararajan R; Giri P; Madhivanan S; Ramesh A; Kishore NK; Manjunatha M; Camarillo IG
Appl Biochem Biotechnol; 2022 Jan; 194(1):517-528. PubMed ID: 34637110
[TBL] [Abstract][Full Text] [Related]
15. Ultra-microsecond pulsed curcumin for effective treatment of triple negative breast cancers.
Mittal L; Raman V; Camarillo IG; Sundararajan R
Biochem Biophys Res Commun; 2017 Sep; 491(4):1015-1020. PubMed ID: 28780353
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of reactive oxygen species production in triple negative breast cancer cells treated with electric pulses and resveratrol.
Giri P; Camarillo IG; Sundararajan R
Explor Target Antitumor Ther; 2023; 4(1):42-56. PubMed ID: 36937321
[TBL] [Abstract][Full Text] [Related]
17. The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention.
Zordoky BN; Bark D; Soltys CL; Sung MM; Dyck JR
Biochim Biophys Acta; 2014 Jun; 1840(6):1943-57. PubMed ID: 24462945
[TBL] [Abstract][Full Text] [Related]
18. High-throughput, Label-free Proteomics Identifies Salient Proteins and Genes in MDA-MB-231 Cells Treated with Natural Neem-based Electrochemotherapy.
Varadarajan G; Thulasidas JS; Giri P; Camarillo IG; Sundararajan R
Appl Biochem Biotechnol; 2022 Jan; 194(1):148-166. PubMed ID: 34993768
[TBL] [Abstract][Full Text] [Related]
19. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
20. Effect of metformin on estrogen and progesterone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cells.
Amaral I; Silva C; Correia-Branco A; Martel F
Biomed Pharmacother; 2018 Jun; 102():94-101. PubMed ID: 29550639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
